Gene Environment Interplay in Substance Use Disorders (R01) | Apply Online

Frequently Asked Questions (FAQs): Gene Environment Interplay in Substance Use Disorders (R01) - PA-11-235

What is the Gene Environment Interplay in Substance Use Disorders (R01) opportunity?

This is an NIH discretionary research funding opportunity that uses the R01 research project grant mechanism to support studies on how genetic factors and environmental experiences work together (interact) to influence the risk for, development of, and recovery from substance use disorders and alcohol use disorders.

Which NIH institutes are involved in this funding opportunity?

The opportunity is funded through the National Institutes of Health (NIH) and is jointly emphasized by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

What types of conditions does this opportunity focus on?

The focus is on substance use disorders and alcohol use disorders, including how these conditions develop, persist, remit, and relate to adverse outcomes over time.

What does "gene-environment interplay" mean in the context of this opportunity?

In this program, gene-environment interplay refers to research that can explain (1) how environmental contexts can amplify, reduce, or redirect genetic risk and (2) how genetic differences can influence a person's sensitivity to particular environments. The emphasis is on clarifying why genetics alone does not explain differences in initiation, escalation, comorbidity, or severity across individuals.

Why is there an emphasis on development and the lifespan?

The announcement highlights that substance use disorders are strongly tied to development across the lifespan. Applicants are encouraged to study developmental trajectories and key transitions, such as first exposure, initiation, progression to problematic use and dependence, persistence versus desistance, and the emergence of adverse outcomes.

What kinds of research questions are especially encouraged?

Projects are encouraged to address questions like why one person initiates use early, escalates quickly, develops comorbid mental health problems, or experiences severe consequences while another does not, and how genetic risk and environmental exposures combine to shape those paths.

What developmental transitions are specifically called out as priorities?

The announcement specifically encourages research on transitions such as: first exposure and initiation; progression from use to problematic use and dependence; persistence versus desistance; and the emergence of adverse outcomes.

How does the opportunity address comorbidity with other conditions?

A major theme is comorbidity, recognizing that substance use disorders often co-occur with other psychiatric or behavioral conditions. Studies that can map shared versus distinct genetic liabilities and environmental exposures that contribute to overlapping outcomes are especially relevant, particularly when they address timing, directionality, and mechanisms across development.

What does the announcement mean by "genetically informative approaches"?

The opportunity calls for genetically informative approaches, meaning designs and methods that can rigorously separate, compare, or combine genetic and environmental contributions. The announcement does not require a single specific design, but the intent is to support studies that can address major methodological challenges in gene-environment research.

What methodological challenges does the opportunity highlight?

The announcement points to challenges such as accurate measurement of complex environments, avoiding confounding between genes and environments, and improving the validity of conclusions about gene-environment interplay.

What is meant by improving "phenotyping" in this program?

The opportunity emphasizes refining how substance use disorders are defined and measured (phenotyping). This includes moving beyond broad diagnostic labels to capture more precise traits, symptom dimensions, course patterns, and intermediate outcomes that may be closer to underlying mechanisms.

Is translation to prevention or treatment part of the goal?

Yes. The agencies emphasize translation, aiming not only to improve basic understanding of risk but also to produce knowledge that can inform prevention strategies, treatment development or tailoring, and future gene-finding and molecular studies.

How might funded research be used in real-world settings?

By clarifying when and how environmental factors matter most for people with certain genetic profiles, this research could point to specific windows for intervention, identify modifiable environmental targets, and help interpret genetic findings in real-world contexts.

What funding mechanism is used for this opportunity?

This opportunity uses the NIH R01 research project grant mechanism.

What are the associated CFDA program numbers?

The opportunity is associated with CFDA 93.273 (Alcohol Research Programs) and CFDA 93.279 (Drug Abuse and Addiction Research Programs).

Are cost sharing or matching funds required?

No. Cost sharing or matching is not required for this opportunity.

Is this funding opportunity currently open?

No. The information provided indicates it is an archived announcement rather than an active open call. It was posted July 19, 2011, had an original closing date of September 7, 2014, a listed current closing date of January 7, 2015, and an archive date of February 7, 2015.

Who is eligible to apply?

Eligibility is broad and includes many organization types that commonly apply for NIH funding. Eligible applicants include public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (including small businesses and other for-profits); and multiple levels of government (state, county, city or township, special district governments, independent school districts, and public housing authorities including Indian housing authorities).

Are tribal governments and tribal organizations eligible?

Yes. The announcement explicitly includes tribal governments and tribal organizations, as well as tribally controlled colleges and universities.

Are mission-focused and minority-serving institutions included in eligibility?

Yes. The announcement explicitly includes historically black colleges and universities, hispanic serving institutions, and alaska native and native hawaiian serving institutions.

Can faith-based or community-based organizations apply?

Yes. Faith-based or community-based organizations are included among eligible applicants, along with regional organizations.

Are foreign (non-U.S.) organizations eligible to apply?

Yes. The announcement states that foreign organizations and foreign institutions may apply. It also allows non-domestic components of U.S. organizations, supporting international collaboration when scientifically justified.

What is the Funding Opportunity Announcement (FOA) identifier for this program?

The archived funding opportunity is identified as PA-11-235.

Where can the official archived announcement be found?

The archived NIH Grants Guide listing is available at: http://grants.nih.gov/grants/guide/pa-files/PA-11-235.html

Who should be contacted for technical issues accessing the announcement?

For technical issues accessing the announcement, the listed contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.